Weight-loss injections are being hailed as a modern medical breakthrough, but experts warn they are not cosmetic quick fixes.

The Subject Expert Committee (SEC) under the Central Drugs Standard Control Organisation (CDSCO) has recommended granting ...

Eli Lilly and Company today announced positive topline results from the ATTAIN-MAINTAIN trial. The Phase 3 study evaluated orforglipron, an investigational, once-daily oral small molecule ...

The diabetes medication semaglutide has recently become a trendy weight loss treatment. But like every drug, there are ...

People who switched to the experimental daily GLP-1 pill orforglipron were able to maintain their weight loss after stopping ...

Though it hasn't even wrapped up clinical trials, the weight loss drug retatrutide already has a cult following.

Frank Athen Walls' victims include a 19-year-old junior college student who was sunbathing and a young Air Force couple who ...

A third-generation PCSK9 inhibitor, lerodalcibep is indicated as an adjunct to diet and exercise to reduce LDL cholesterol in ...

Topline results from the ATTAIN-MAINTAIN trial show that orforglipron, an investigational oral GLP-1 RA, helps people ...

The FDA has approved lerodalcibep-liga, a third-generation injectable PCSK9 inhibitor, to reduce LDL cholesterol in adults ...

Lerodalcibep-liga, a once-monthly PCSK9 inhibitor, significantly reduces LDL-C in hypercholesterolemia, including HeFH, with ...

The U.S. has registered over half a million clinical trials since 2000. Here's a look at the business and ethics of human ...